Mechanisms of Hyperplasia

Slide 1 · Mechanisms of Hyperplasia

From mitogenic signals to increased cell number

Cell proliferation • tissue stem cells • regeneration • pathologic growth

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain the two cellular sources of increased cell number: Mature-cell division and stem-cell output.

Trace growth-factor signaling to cell-cycle entry and proliferation.

Apply these mechanisms to liver, bone marrow and hormone-responsive tissues.

Distinguish regulated hyperplasia from neoplastic proliferation.

Emphasis: Stimulus → cellular response → tissue consequence.

Slide 3 · Hyperplasia changes cell number, not merely cell size

Baseline

Hyperplasia

An increase in the number of constituent cells expands tissue mass in response to a stimulus.

Slide 4 · Hyperplasia and hypertrophy are distinct adaptations

Feature

Hyperplasia

Hypertrophy

Primary change

More cells

Larger individual cells

Requirement

Cells capable of division

Cell enlargement without cell division

Relationship

May coexist with hypertrophy

May coexist with hyperplasia

Slide 5 · A proliferative cell pool is essential

Hyperplasia requires mature cells able to enter the cell cycle or a stem/progenitor pool.

Nonproliferative cell populations have limited ability to expand by cell division.

Tissue-specific proliferative potential helps predict the response to a growth stimulus.

Cell number cannot increase through hypertrophy alone.

Slide 6 · Two complementary cellular sources of hyperplasia

Growth-factor or hormonal stimulation

Mature-cell route

Division of surviving differentiated cells

Stem-cell route

Expansion and maturation of tissue stem-cell progeny

Relative contribution depends on tissue and injury context.

Slide 7 · From initiating stimulus to tissue enlargement

Stimulus

Growth signals

Cell-cycle entry

More daughter cells

Increased cell number

A regulated response links extracellular cues to intracellular proliferation.

Slide 8 · Physiologic versus pathologic stimulation

Dimension

Physiologic

Pathologic

Typical purpose

Meet functional demand or replace lost cells

Response to excessive/inappropriate signals

Illustration

Pregnancy breast; Liver after resection

Endometrial or prostatic hyperplasia

Control

Feedback-limited

Often remains stimulus-dependent

Slide 9 · Hormonal hyperplasia increases functional capacity

Physiologic hormonal cue

Responsive glandular cells

Proliferation ± cell enlargement

Greater tissue capacity

Mammary glandular epithelium expands during puberty and pregnancy.

Slide 10 · Compensatory hyperplasia replaces lost tissue mass

Resection or cell loss

Locally produced signals

Division of remaining cells

Partial mass restoration

Liver regeneration is the classic illustration.

Slide 11 · Marrow compensates for erythrocyte deficit

Hemorrhage or hemolysis

Increased erythropoietin signaling

Red-cell progenitor expansion

Higher erythrocyte output

Feedback couples a circulating deficit to marrow proliferation.

Slide 12 · Abnormal growth signals can remain regulated

Excess hormones or growth factors can produce pathologic hyperplasia.

The target cells still respond to extracellular cues and regulatory pathways.

Regression or stabilization may follow removal of the driving hormonal signal.

Stimulus dependence helps separate hyperplasia from autonomous neoplasia.

Slide 13 · The endometrium illustrates hormonal balance

Estrogen-dominant interval

Estrogen promotes endometrial proliferative activity.

Glandular cellularity increases during the proliferative phase.

Progesterone influence

Progesterone counterbalances proliferative stimulation.

Normal cycling prevents sustained unopposed gland proliferation.

Slide 14 · Unopposed estrogen favors glandular expansion

Relative/absolute estrogen excess

Sustained epithelial mitogenic stimulus

Endometrial gland proliferation

Abnormal uterine bleeding

The clinical symptom follows from abnormal endometrial growth and cycling.

Slide 15 · Androgen signaling drives prostatic hyperplasia

Androgenic stimulation

Hormone-responsive prostate cells

Increased cellular proliferation

Benign prostatic enlargement

An endocrine input can provoke a non-neoplastic mass increase.

Slide 16 · Viral proteins can dysregulate proliferation

Papillomavirus infection

Viral interference with host regulators

Hyperplastic epithelial proliferation

Warts / mucosal lesions

Viral hyperplasia highlights a mechanism other than hormonal excess.

Slide 17 · Reversibility reflects stimulus dependence

Stimulus removed

Mitogenic drive falls

Proliferative response slows

Regression or stabilization

The source describes hormone-dependent hyperplasia as remaining controlled.

Slide 18 · Regulated proliferation differs from neoplasia

Question

Hyperplasia

Neoplasia

Primary driver

An external growth signal

Acquired autonomous growth advantage

Response to cue withdrawal

Can regress or stabilize

May persist independently

Relationship

May create a risk context

Represents a distinct clonal disease process

Slide 19 · Growth factors are the proximate mitogenic signal

Growth factor availability

Binding to target-cell receptor

Signal transduction

Cell-cycle gene expression

Cell division

Both homeostatic proliferation and injury responses use these steps.

Slide 20 · Growth factors act through tissue-specific contexts

Source or factor

Representative source

Relevant effect

HGF

Liver stromal / nonhepatocyte cells

Hepatocyte mitogenesis

TGF-α

Macrophages, keratinocytes and others

Epithelial / hepatocyte proliferation

EGF

Macrophages and epithelia

Many epithelial proliferative responses

Slide 21 · Activated macrophages supply local repair signals

Macrophages become activated at sites of tissue damage.

They provide growth factors that stimulate reparative proliferation.

The same tissue response also recruits stromal, vascular and epithelial contributions.

The injury microenvironment helps determine which cells expand.

Slide 22 · Growth signals come from more than one cell type

Parenchymal and epithelial cells

Surviving local cells may secrete mitogenic factors.

Their receptors may also respond to neighboring factors.

Stromal and inflammatory cells

Macrophages and fibroblasts contribute growth-factor signals.

Extracellular matrix can hold factors near responding cells.

Slide 23 · Receptor recognition links ligand to response

Extracellular growth factor

Compatible surface receptor

Receptor activation

Downstream signaling

Proliferative transcription

A cell must be competent to recognize and transduce the signal.

Slide 24 · RAS–RAF–MAPK transduces a mitogenic signal

Growth-factor receptor

Adaptor-mediated RAS activation

RAF kinase

MAPK signaling

Transcriptional response

A representative pathway; Not every growth signal uses this exact sequence.

Slide 25 · Activated receptors engage multiple outputs

Phosphorylated growth-factor receptor

Mitogenic arm

RAS / RAF / MAPK → gene expression

Parallel signaling

PI3K-dependent downstream effects

Signaling networks branch; Avoid equating one receptor with one linear pathway.

Slide 26 · Transcription converts a transient cue into a cellular program

Signal-dependent transcription factors

Growth-related gene expression

Cycle-entry and survival programs

Proliferative response

The source discusses MYC and JUN among growth-promoting transcriptional regulators.

Slide 27 · Growth-factor signaling coordinates four major outputs

Output

Mechanistic consequence

Cell-cycle entry

Quiescent cells acquire proliferative competence

Checkpoint progression

Inhibitory barriers may be appropriately relieved

Cell survival

Apoptotic loss is reduced

Macromolecule synthesis

DNA, protein, membrane and organelle production increases

Slide 28 · Hyperplasia requires survival as well as division

Mitogenic stimulation

Cell-cycle progression + survival signals

Net accumulation of living cells

Net cell number reflects production balanced against cellular loss.

Slide 29 · Daughter cells require new biomass

Mitogenic signaling

Nucleic acid and protein synthesis

Membranes and organelles

Mitosis and cytokinesis

DNA replication alone is insufficient for successful proliferation.

Slide 30 · Quiescent cells can re-enter the cycle

Stable cell in G₀

Appropriate growth signal

Entry into G₁

DNA synthesis (S)

Division

Residual hepatocytes are an important example of a quiescent proliferative pool.

Slide 31 · Cell-cycle phases are ordered, not interchangeable

G₁: Growth

S: DNA replication

G₂: Preparation

M: Mitosis

Quiescence (G₀) is a separate state that can precede G₁ entry.

Slide 32 · Cyclins and CDKs govern cycle transitions

Cyclin accumulation

Cyclin–CDK activation

Substrate phosphorylation

Phase progression

Sequential cyclins D, E, A and B participate in coordinated transitions.

Slide 33 · DNA surveillance accompanies proliferation

Checkpoint

Question assessed

Protective response

G₁/S

Is DNA suitable for replication?

Delay cycle to permit repair

G₂/M

Was genome replication accurate?

Delay division if abnormalities persist

Irreparable injury

Can safe division resume?

Apoptosis or senescence

Slide 34 · Normal mitogenesis is constrained by inhibitors

Cyclin-dependent kinase inhibitors counterbalance growth-promoting complexes.

Checkpoint activation can pause proliferation while DNA damage is repaired.

Cellular senescence or apoptosis prevents propagation of irreparable injury.

Hyperplasia engages proliferative machinery; It does not require its complete deregulation.

Slide 35 · Extracellular matrix provides a permissive context

Preserved tissue framework

Matrix-bound growth factors

Integrin-mediated cell signals

Organized cell proliferation

An intact extracellular matrix supports effective regeneration.

Slide 36 · Matrix and soluble signals converge

Tissue cell

Soluble route

Growth factors → receptors

Adhesion route

ECM → integrins

These inputs can jointly facilitate cell proliferation and survival.

Slide 37 · Stem-cell niches regulate the reserve pool

Specialized microenvironment

Stem-cell quiescence / activation

Self-renewal and lineage commitment

Replacement mature cells

Niches maintain local progenitors until homeostasis or injury calls on them.

Slide 38 · Asymmetric division preserves a stem-cell pool

Tissue stem cell

Asymmetric division

One renewing stem cell + one committed daughter

Differentiated progeny

Balanced renewal supports ongoing replacement without exhausting the pool.

Slide 39 · Symmetric division expands stem-cell numbers

Stem-cell activation

Symmetric self-renewal

Two stem-like daughters

Expanded reserve pool

Symmetric expansion under strong demands, such as marrow recovery.

Slide 40 · Mature-cell and stem-cell routes are complementary

Feature

Residual mature cell

Tissue stem cell

Starting point

Differentiated surviving cell

Relatively undifferentiated niche cell

Required step

Re-entry into cell cycle

Expansion and differentiation

Contribution

Direct increase of functional cells

Replenishes mature population

Slide 41 · Proliferative potential predicts adaptive capacity

Tissue class

Baseline state

Examples

Labile

Continuous cell replacement

Surface epithelia, marrow

Stable

Mostly quiescent; Recruitable

Liver, kidney; Fibroblasts

Permanent

Very limited cell replication

Most neurons, cardiac myocytes

Slide 42 · Labile tissues routinely depend on renewal

Surface epithelium

Cells are continuously lost and replaced.

Preserved stem cells make regeneration feasible.

Bone marrow

Hematopoietic progenitors continually produce mature cells.

Growth signals can rapidly expand lineage output.

Slide 43 · Stable hepatocytes are recruitable from G₀

Intact resting hepatocyte

Loss of liver mass

Growth-factor competence

Cell-cycle re-entry

Replacement hepatocytes

Quiescence is not equivalent to terminal differentiation.

Slide 44 · Permanent tissues exemplify the limit

Neurons and cardiomyocytes

Most cells have little useful adult proliferative capacity.

Severe losses are not compensated by bulk hyperplasia.

Regenerative exceptions

Skeletal muscle satellite cells can supply some repair.

Restricted replication in brain/heart is insufficient for full restoration.

Slide 45 · Cell source determines the route of tissue reconstitution

Mature-cell division

Stem-cell output

Stem → progenitor → mature cells

The same net increase in cell number may arise from division of residual cells or stem-cell maturation.

Slide 46 · Liver regeneration is a two-route model

Liver mass loss / injury

Residual hepatocyte division

Prominent after partial hepatectomy

Stem-cell contribution

More relevant when hepatocyte division is impaired

The dominant route depends on the type and persistence of injury.

Slide 47 · Partial hepatectomy initiates compensatory growth

Reduced liver mass

Cytokine / growth-factor release

Residual hepatocyte proliferation

Restored liver cell mass

This is compensatory hyperplasia rather than enlargement of hepatocytes alone.

Slide 48 · IL-6 primes surviving hepatocytes

Injury-associated Kupffer cell activation

IL-6 release

Hepatocyte priming

Growth-factor responsiveness

Cytokine priming before strong mitogenic signaling.

Slide 49 · HGF and TGF-α stimulate the primed liver

Growth-factor production

HGF and TGF-α signaling

Hepatocyte proliferation

Regenerating liver mass

Priming and growth-factor drive are complementary stages.

Slide 50 · HGF signals through the MET receptor

HGF from stromal and liver-associated cells

HGF binding to MET

Receptor tyrosine-kinase signal

Hepatocyte mitogenesis

HGF–MET is a named receptor-ligand pair Chapter 1.

Slide 51 · Residual hepatocytes drive much hepatic regrowth

After partial hepatectomy, surviving hepatocytes retain replicative competence.

Cytokines make them responsive to growth factors, followed by mitotic expansion.

Extensive human liver regeneration can follow proliferation of residual hepatocytes.

Do not equate restored organ mass with exact restoration of resected architecture.

Slide 52 · Chronic damage changes the dominant cell source

Hepatocyte proliferative capacity

Preserved

Residual mature hepatocyte division predominates

Compromised

Intrahepatic stem-cell contribution becomes important

Mechanistic emphasis changes with the condition of the surviving cells.

Slide 53 · Canals of Hering are a hepatic stem-cell niche

Chronic hepatic injury

Hepatocyte proliferation impaired

Stem-cell niches near canals of Hering

Mature hepatocyte replenishment

The source locates some hepatic stem cells near bile canaliculi–duct connections.

Slide 54 · Regeneration competes with scar formation

Outcome

Regeneration

Fibrous repair

Biologic basis

Replacement of functional cells

Collagen-rich connective tissue deposition

Requirements

Proliferative capacity + preserved ECM

More important when structural injury is severe

Tissue result

Restoration toward normal

Mechanical continuity; Altered architecture

Slide 55 · Erythropoietin couples demand to marrow output

Reduced circulating erythrocytes

Erythropoietin feedback

Erythroid progenitor proliferation

Enhanced red-cell production

Hemorrhage and hemolysis to illustrate compensatory marrow hyperplasia.

Slide 56 · Pathologic and physiologic signals differ by context

Feature

Compensatory growth

Excess hormonal growth

Initiating problem

Functional cell or tissue deficit

Inappropriately sustained stimulus

Illustration

Liver resection / anemia

Endometrial estrogen excess

Response principle

Growth-factor-driven proliferation

Growth-factor or hormone-driven proliferation

Slide 57 · Papillomavirus adds a distinct proliferative mechanism

Viral infection

Viral proteins alter host cycle regulators

Epithelial hyperplasia

Potential precursor context

This is not identical to ordinary growth-factor-stimulated liver regeneration.

Slide 58 · More mitoses can increase mutation opportunities

Sustained cell turnover

Repeated DNA replication

Chance of acquiring genetic errors

Possible neoplastic progression

Risk does not imply that every hyperplastic lesion is precancerous.

Slide 59 · Cancer risk depends on the hyperplastic context

Context

Proliferative stimulus

Clinical interpretation

Compensatory liver growth

Demand after loss of tissue mass

Adaptive replacement of hepatocytes

Endometrial hyperplasia

Sustained relative / absolute estrogen excess

Some patients face increased cancer risk

Papillomavirus lesions

Viral interference with cell-cycle regulators

Some lesions are cancer precursors

Slide 60 · Clinical reasoning: Abnormal uterine bleeding

Teaching vignette (hypothetical)

A patient has persistent bleeding with a sustained estrogenic effect relative to progesterone.

Which proliferative mechanism could expand the endometrium?

Mechanistic interpretation: Hormone-driven epithelial proliferation increases endometrial glandular cellularity; Evaluate histology clinically.

Slide 61 · Clinical reasoning: Living liver donation

Teaching vignette (hypothetical)

A healthy donor undergoes partial hepatectomy with viable residual hepatocytes.

Which cell source should supply most early compensatory proliferation?

Mechanistic interpretation: Residual differentiated hepatocytes respond to cytokine priming and growth factors, then re-enter the cell cycle.

Slide 62 · Clinical reasoning: Hemolysis

Teaching vignette (hypothetical)

Accelerated erythrocyte destruction produces a sustained demand for replacement.

Which signal links the deficit to expansion of the marrow cell pool?

Mechanistic interpretation: Feedback involving erythropoietin expands erythroid precursors, increasing new erythrocyte output.

Slide 63 · Clinical reasoning: Chronically injured liver

Teaching vignette (hypothetical)

Chronic hepatic inflammation has impaired the ability of surviving hepatocytes to proliferate.

Which additional source of mature hepatocytes becomes relevant?

Mechanistic interpretation: Intrahepatic stem-cell contributions, including niches in the canals of Hering.

Slide 64 · Integrated model of adaptive cell-number increase

A signal-responsive tissue

Mature-cell proliferation

Growth factor → receptor → cell cycle → daughter cells

Stem/progenitor output

Niche activation → expansion → differentiated progeny

The extent and success of expansion depend on signals, cell competence and ECM.

Slide 65 · Mechanistic synthesis

Hyperplasia is growth-stimulus–dependent expansion of cell number.

In most settings, competent mature cells proliferate in response to growth factors.

Tissue stem cells replenish populations, particularly when mature-cell division is limited.

Physiologic and pathologic hyperplasia share machinery but differ in stimulus and consequences.

Clinical interpretation begins by identifying the stimulus, cell source and tissue context.

Slide 66 · Principal textbook sections

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026). Chapter 2: Hyperplasia; Mechanisms of Hyperplasia.

Chapter 3: Cell and Tissue Regeneration; Liver Regeneration.

Chapter 1: Growth Factors and Receptors; Proliferation and the Cell Cycle; Stem Cells.

References and source locators are detailed in the speaker notes.